These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 29177679)
1. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Tan CH; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Dillon WP; Bonham LW; Yokoyama JS; Karch CM; Brewer JB; Rabinovici GD; Miller BL; Schellenberg GD; Kauppi K; Feldman HA; Holland D; McEvoy LK; Hyman BT; Bennett DA; Andreassen OA; Dale AM; Desikan RS; Acta Neuropathol; 2018 Jan; 135(1):85-93. PubMed ID: 29177679 [TBL] [Abstract][Full Text] [Related]
2. Sex modulates the ApoE ε4 effect on brain tau deposition measured by Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194 [TBL] [Abstract][Full Text] [Related]
3. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease. Cody KA; Langhough RE; Zammit MD; Clark L; Chin N; Christian BT; Betthauser TJ; Johnson SC Brain; 2024 Jun; 147(6):2144-2157. PubMed ID: 38667631 [TBL] [Abstract][Full Text] [Related]
4. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers. Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C; Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]
6. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052 [TBL] [Abstract][Full Text] [Related]
8. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study. Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM; J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495 [TBL] [Abstract][Full Text] [Related]
9. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects. Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987 [TBL] [Abstract][Full Text] [Related]
10. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences. de Wilde A; Reimand J; Teunissen CE; Zwan M; Windhorst AD; Boellaard R; van der Flier WM; Scheltens P; van Berckel BNM; Bouwman F; Ossenkoppele R Alzheimers Res Ther; 2019 Sep; 11(1):78. PubMed ID: 31511058 [TBL] [Abstract][Full Text] [Related]
11. Alzheimer's pathology targets distinct memory networks in the ageing brain. Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481 [TBL] [Abstract][Full Text] [Related]
12. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease. Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA; Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519 [TBL] [Abstract][Full Text] [Related]
13. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age. Betthauser TJ; Koscik RL; Jonaitis EM; Allison SL; Cody KA; Erickson CM; Rowley HA; Stone CK; Mueller KD; Clark LR; Carlsson CM; Chin NA; Asthana S; Christian BT; Johnson SC Brain; 2020 Jan; 143(1):320-335. PubMed ID: 31886494 [TBL] [Abstract][Full Text] [Related]
14. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. Lowe VJ; Wiste HJ; Senjem ML; Weigand SD; Therneau TM; Boeve BF; Josephs KA; Fang P; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR Brain; 2018 Jan; 141(1):271-287. PubMed ID: 29228201 [TBL] [Abstract][Full Text] [Related]
15. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. Hohman TJ; Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Bennett DA; Schneider JA; Jefferson AL; JAMA Neurol; 2018 Aug; 75(8):989-998. PubMed ID: 29801024 [TBL] [Abstract][Full Text] [Related]
17. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
18. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease. Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812 [TBL] [Abstract][Full Text] [Related]
19. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia. Jack CR; Wiste HJ; Therneau TM; Weigand SD; Knopman DS; Mielke MM; Lowe VJ; Vemuri P; Machulda MM; Schwarz CG; Gunter JL; Senjem ML; Graff-Radford J; Jones DT; Roberts RO; Rocca WA; Petersen RC JAMA; 2019 Jun; 321(23):2316-2325. PubMed ID: 31211344 [TBL] [Abstract][Full Text] [Related]
20. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]